Biomaterial Database

Management of indinavir associated nephrolithiasis. 1997

J D Rich, and B Ramratnam, and M Chiang, and K T Tashima

Department of Medicine, Miriam Hospital, Providence, Rhode Island, USA.

UI	MeSH Term	Description	Entries
D008297	Male		Males
D006679	HIV Seropositivity	Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).	AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D014514	Ureteral Calculi	Stones in the URETER that are formed in the KIDNEY. They are rarely more than 5 mm in diameter for larger renal stones cannot enter ureters. They are often lodged at the ureteral narrowing and can cause excruciating renal colic.	Ureteral Calculus,Calculi, Ureteral,Calculus, Ureteral
D017320	HIV Protease Inhibitors	Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly.	HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D019469	Indinavir	A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.	Crixivan,Indinavir Sulfate,Indinavir, Sulfate (1:1),L-735 524,L-735,524,MK-639,L 735 524,L 735,524,L735 524,L735,524,MK 639,MK639,Sulfate, Indinavir

Related Publications

J D Rich, and B Ramratnam, and M Chiang, and K T Tashima

Nephrolithiasis on indinavir.

February 1999, Prescrire international,

J D Rich, and B Ramratnam, and M Chiang, and K T Tashima

Indinavir nephrolithiasis in warm climates.

March 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,

J D Rich, and B Ramratnam, and M Chiang, and K T Tashima

Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients.

December 1998, AIDS (London, England),

J D Rich, and B Ramratnam, and M Chiang, and K T Tashima

Persistent nephrolithiasis after discontinuation of indinavir therapy.

December 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,

J D Rich, and B Ramratnam, and M Chiang, and K T Tashima

Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy.

June 2011, International urology and nephrology,

J D Rich, and B Ramratnam, and M Chiang, and K T Tashima

Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophy in two HIV-1 infected children.

September 2001, AIDS (London, England),